These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1337267)

  • 41. [Involuntary movement and neurotransmitter systems].
    Ogawa N
    Nihon Rinsho; 1993 Nov; 51(11):2811-5. PubMed ID: 7903985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impact of the motor complications of Parkinson's disease on the quality of life.
    Chapuis S; Ouchchane L; Metz O; Gerbaud L; Durif F
    Mov Disord; 2005 Feb; 20(2):224-30. PubMed ID: 15384126
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of extrapyramidal disorders.
    Marsden CD; Schachter M
    Br J Clin Pharmacol; 1981 Feb; 11(2):129-51. PubMed ID: 6452152
    [No Abstract]   [Full Text] [Related]  

  • 44. The emerging role of clozapine in the treatment of movement disorders.
    Factor SA; Friedman JH
    Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of Parkinson's disease].
    Guillard A
    Rev Prat; 1989 Mar; 39(8):653-7. PubMed ID: 2727572
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
    Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
    J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Genetic considerations in movement disorders.
    Wszolek ZK; Pfeiffer RF
    Curr Opin Neurol Neurosurg; 1992 Jun; 5(3):324-30. PubMed ID: 1623259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Stability of the head: studies in normal subjects and in patients with labyrinthine disease, head tremor, and dystonia.
    Gresty M
    Mov Disord; 1987; 2(3):165-85. PubMed ID: 3504548
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sensory phenomena in Tourette's syndrome.
    Scahill LD; Leckman JF; Marek KL
    Adv Neurol; 1995; 65():273-80. PubMed ID: 7872145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sensorimotor integration: basic concepts, abnormalities related to movement disorders and sensorimotor training-induced cortical reorganization.
    Machado S; Cunha M; Velasques B; Minc D; Teixeira S; Domingues CA; Silva JG; Bastos VH; Budde H; Cagy M; Basile L; Piedade R; Ribeiro P
    Rev Neurol; 2010 Oct; 51(7):427-36. PubMed ID: 20859923
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Psychosomatic aspects of movement disorders.
    Cummings JL
    Adv Psychosom Med; 1985; 13():111-32. PubMed ID: 2931005
    [No Abstract]   [Full Text] [Related]  

  • 52. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders.
    Crossman AR
    Neuroscience; 1987 Apr; 21(1):1-40. PubMed ID: 2955248
    [No Abstract]   [Full Text] [Related]  

  • 53. Movement disorders at a university hospital emergency room. An analysis of clinical pattern and etiology.
    Yoon JH; Lee PH; Yong SW; Park HY; Lim TS; Choi JY
    J Neurol; 2008 May; 255(5):745-9. PubMed ID: 18338197
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Orofacial dyskinesias and dystonia in rats infected with Borna disease virus; a model for tardive dyskinetic syndromes.
    Solbrig M; Koob G; Lipkin W
    Mol Psychiatry; 1999 Jul; 4(4):310-2. PubMed ID: 10483043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of movement disorders.
    Tanner CM; Goldman SM
    Curr Opin Neurol; 1994 Aug; 7(4):340-5. PubMed ID: 7952243
    [No Abstract]   [Full Text] [Related]  

  • 56. Impairment of optokinetic nystagmus in patients with tardive dyskinesia.
    Lipper S
    Arch Gen Psychiatry; 1973 Mar; 28(3):331-3. PubMed ID: 4143946
    [No Abstract]   [Full Text] [Related]  

  • 57. [The influence of sleep on abnormal waking movements].
    Autret A; Lucas B; Henry F; Saudeau D; de Toffol B
    Neurophysiol Clin; 1994 Jun; 24(3):218-26. PubMed ID: 8090155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Drug-induced tremor and acute movement disorders].
    Montastruc JL; Durrieu G
    Therapie; 2004; 59(1):97-103. PubMed ID: 15202422
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional gait disorders, clinical phenomenology, and classification.
    Baizabal-Carvallo JF; Alonso-Juarez M; Jankovic J
    Neurol Sci; 2020 Apr; 41(4):911-915. PubMed ID: 31832998
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional Movement Disorders in Elderly.
    Chouksey A; Pandey S
    Tremor Other Hyperkinet Mov (N Y); 2019; 9():. PubMed ID: 31413900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.